Back-table specimen scanning using gantry-free hybrid hSPECT/LiDAR imaging: a feasibility study during PSMA-radioguided surgery
- PMID: 40854999
- PMCID: PMC12500833
- DOI: 10.1007/s00464-025-12081-w
Back-table specimen scanning using gantry-free hybrid hSPECT/LiDAR imaging: a feasibility study during PSMA-radioguided surgery
Abstract
Introduction: Prostate-specific membrane antigen (PSMA) targeted precision surgery is becoming increasingly popular. However, the relatively low levels of PSMA-receptor expression and background signal can hinder in vivo lesion detection and margin evaluation. Back-table imaging (ex vivo) potentially provides a means to confirm surgical accuracy. For 99mTc-PSMA-radioguided surgery, an innovative gantry-free hybrid imaging technique has recently been proposed, namely handheld single-photon emission computed tomography (hSPECT) combined with light detection and ranging (LiDAR). This study aimed to assess the feasibility and performance of hSPECT/LiDAR in analyzing tissue specimens excised after robotic 99mTc-PSMA-radioguided surgery.
Methods: We included samples from 5 prostate cancer patients undergoing primary or salvage robot-assisted resection of 99mTc-PSMA-I&S avid lesions that were identified using a drop-in gamma probe. 12 samples (1 prostatic tissue, 1 local recurrence tissue, 10 lymph nodes) were analyzed ex vivo using a custom-built specimen tray, including an optical reference tracker for scan registration. LiDAR was used to acquire a surface scan of the specimens, and the 3D OBJ image output was fused with the 3D DICOM of a hSPECT obtained using a handheld gamma camera and DeclipseSPECT tracking system.
Results: hSPECT/LiDAR imaging provided accurate representation of the 99mTc-PSMA-I&S uptake within the specimens. In 8 samples, it helped to confirm a true positive lesion. In the remaining 4 samples, non-visualization aligned with negative histopathology (true negative). A strong correlation was found between PSMA-hSPECT/LiDAR and PSMA-PET/CT (p < 0.05), but no correlation could be established with PSMA-SPECT/CT (p = 0.515). The count rates fount in the scan correlated to tumor size (p = 0.016) and were not influenced by the overall specimen's size (p = 0.558).
Conclusion: We present the technical feasibility of a new 3D hybrid modality (hSPECT/LiDAR) that allows back-table assessment of surgical specimens from the already well validated robotic 99mTc-PSMA-radioguided surgery workflow.
Keywords: Image-guided surgery; PSMA SPECT/CT/LiDAR; Prostate cancer; Radioguided surgery; Specimen scanning; Surface scanning.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Disclosures: BAÇ is an employee of Crystal Photonics; however, the company had no role in the design or reporting of the study. GP, MNvO, VAO, ACB, LJS, DDDR, HGvdP, PJvL, FWBvL have no disclosures to state.
Figures
References
-
- Maurer T, Gschwend JE, Rauscher I, Souvatzoglou M, Haller B, Weirich G et al (2016) Diagnostic efficacy of (68)gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer. J Urol 195:1436–1443 - PubMed
-
- Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I et al (2020) Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer-updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis. Eur Urol 77:403–417 - PubMed
-
- Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P et al (2020) Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 395:1208–1216 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
